• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

香豆素标记的 1,3,4-噁二唑缀合物的合成、计算研究及其对 MDA-MB-231 和 MCF-7 人乳腺癌细胞的抗增殖活性。

Synthesis, computational studies and antiproliferative activities of coumarin-tagged 1,3,4-oxadiazole conjugates against MDA-MB-231 and MCF-7 human breast cancer cells.

机构信息

School of Chemistry and Physics, University of KwaZulu-Natal, P/Bag X54001, Westville, Durban 4000, South Africa.

School of Molecular and Cell Biology, University of the Witwatersrand, Private Bag 3, Wits, Johannesburg 2050, South Africa.

出版信息

Bioorg Med Chem. 2018 Nov 15;26(21):5612-5623. doi: 10.1016/j.bmc.2018.10.006. Epub 2018 Oct 12.

DOI:10.1016/j.bmc.2018.10.006
PMID:30360952
Abstract

A novel library of coumarin tagged 1,3,4 oxadiazole conjugates was synthesized and evaluated for their antiproliferative activities against MDA-MB-231 and MCF-7 breast cancer cell lines. The evaluation studies revealed that compound 9d was the most potent molecule with an IC value of <5 µM against the MCF-7 cell line. Interestingly, compounds 10b and 11a showed a similar trend with lower inhibitory concentration (IC = 7.07 µM), in Estrogen Negative (ER-) cells than Estrogen Positive (ER+) cells. Structure-activity relationship (SAR) studies revealed that conjugates bearing benzyl moieties (9b, 9c and 9d) had superior activities compared to their alkyl analogues. The most potent compound 9d showed ∼1.4 times more potent activity than tamoxifen against MCF-7 cell line; while the introduction of sulfone unit in compounds 11a, 11b and 11c resulted in significant cytotoxicity against both MCF-7 and MDA-MB-231 cell lines. These results were further supported by docking studies, which revealed that the stronger binding affinity of the synthesized conjugates is due to the presence of sulfone unit attached to the substituted benzyl moiety in their pharmacophores.

摘要

合成了一个新型香豆素标记 1,3,4-恶二唑共轭物库,并对其抗 MDA-MB-231 和 MCF-7 乳腺癌细胞系的增殖活性进行了评价。评估研究表明,化合物 9d 是最有效的分子,其对 MCF-7 细胞系的 IC 值小于 5 µM。有趣的是,化合物 10b 和 11a 在雌激素阴性(ER-)细胞中比雌激素阳性(ER+)细胞具有更低的抑制浓度(IC = 7.07 µM),显示出类似的趋势。构效关系(SAR)研究表明,带有苄基部分的共轭物(9b、9c 和 9d)比其烷基类似物具有更高的活性。最有效的化合物 9d 对 MCF-7 细胞系的活性比他莫昔芬高约 1.4 倍;而在化合物 11a、11b 和 11c 中引入砜单元则导致对 MCF-7 和 MDA-MB-231 细胞系都具有显著的细胞毒性。这些结果得到了对接研究的进一步支持,该研究表明,合成的共轭物具有更强的结合亲和力,这是由于其药效团中取代的苄基部分上存在砜单元。

相似文献

1
Synthesis, computational studies and antiproliferative activities of coumarin-tagged 1,3,4-oxadiazole conjugates against MDA-MB-231 and MCF-7 human breast cancer cells.香豆素标记的 1,3,4-噁二唑缀合物的合成、计算研究及其对 MDA-MB-231 和 MCF-7 人乳腺癌细胞的抗增殖活性。
Bioorg Med Chem. 2018 Nov 15;26(21):5612-5623. doi: 10.1016/j.bmc.2018.10.006. Epub 2018 Oct 12.
2
Synthesis, anticancer effect and molecular modeling of new thiazolylpyrazolyl coumarin derivatives targeting VEGFR-2 kinase and inducing cell cycle arrest and apoptosis.合成、抗癌作用及新型噻唑基吡唑并香豆素衍生物的分子模拟,该衍生物针对 VEGFR-2 激酶并诱导细胞周期停滞和细胞凋亡。
Bioorg Chem. 2019 Apr;85:253-273. doi: 10.1016/j.bioorg.2018.12.040. Epub 2019 Jan 3.
3
Design, synthesis and docking studies of novel 4-aminophenol-1,2,4-oxadiazole hybrids as apoptosis inducers against triple negative breast cancer cells targeting MAP kinase.新型 4-氨基酚-1,2,4-恶二唑杂合体的设计、合成及对接研究,作为针对 MAP 激酶的三阴性乳腺癌细胞凋亡诱导剂。
J Biomol Struct Dyn. 2024 Jul;42(11):5841-5857. doi: 10.1080/07391102.2023.2239912. Epub 2023 Aug 2.
4
Synthesis, Cytotoxicity and Antimicrobial Evaluation of New Coumarin-Tagged β-Lactam Triazole Hybrid.新型香豆素标记β-内酰胺三唑杂合体的合成、细胞毒性和抗菌评价。
Chem Biodivers. 2020 Jan;17(1):e1900462. doi: 10.1002/cbdv.201900462. Epub 2020 Jan 9.
5
Design, Synthesis, and Biological Evaluation of 2-(2-Bromo-3-nitrophenyl)-5-phenyl-1,3,4-oxadiazole Derivatives as Possible Anti-Breast Cancer Agents.设计、合成及生物评价 2-(2-溴-3-硝基苯基)-5-苯基-1,3,4-恶二唑衍生物作为潜在的抗乳腺癌药物。
Chem Biodivers. 2020 Feb;17(2):e1900659. doi: 10.1002/cbdv.201900659. Epub 2020 Jan 29.
6
Design, Synthesis and Biological Evaluation of Novel 4-Substituted Coumarin Derivatives as Antitumor Agents.新型 4-取代香豆素衍生物的设计、合成及抗肿瘤活性评价。
Molecules. 2018 Sep 6;23(9):2281. doi: 10.3390/molecules23092281.
7
Synthesis and biological evaluation of new coumarin derivatives as cytotoxic agents.新型香豆素衍生物的合成及细胞毒性评价。
Arch Pharm (Weinheim). 2021 Aug;354(8):e2100029. doi: 10.1002/ardp.202100029. Epub 2021 Apr 19.
8
Design, synthesis and biological evaluation of 2-(phenoxymethyl)-5-phenyl-1,3,4-oxadiazole derivatives as anti-breast cancer agents.设计、合成及生物评价 2-(苯氧甲基)-5-苯基-1,3,4-噁二唑衍生物作为抗乳腺癌药物。
Eur J Med Chem. 2019 Apr 15;168:1-10. doi: 10.1016/j.ejmech.2019.02.033. Epub 2019 Feb 15.
9
Synthesis of novel building blocks of benzosuberone bearing coumarin moieties and their evaluation as potential anticancer agents.含香豆素部分的新型苯并降冰片烯酮结构单元的合成及其作为潜在抗癌剂的评估。
Eur J Med Chem. 2014 May 22;79:260-5. doi: 10.1016/j.ejmech.2014.04.015. Epub 2014 Apr 5.
10
Design, synthesis, modelling studies and biological evaluation of 1,3,4-oxadiazole derivatives as potent anticancer agents targeting thymidine phosphorylase enzyme.设计、合成、建模研究和生物评价 1,3,4-噁二唑衍生物作为靶向胸苷磷酸化酶的有效抗癌剂。
Bioorg Chem. 2021 Jun;111:104873. doi: 10.1016/j.bioorg.2021.104873. Epub 2021 Mar 29.

引用本文的文献

1
A review of the current status of biological effects of plant-derived therapeutics in breast cancer.植物源治疗药物在乳腺癌中的生物学效应现状综述
Mol Biol Rep. 2025 Jan 24;52(1):159. doi: 10.1007/s11033-025-10261-4.
2
Recent Perspectives on Anticancer Potential of Coumarin Against Different Human Malignancies: An Updated Review.香豆素对不同人类恶性肿瘤抗癌潜力的最新观点:综述更新
Food Sci Nutr. 2024 Dec 31;13(1):e4696. doi: 10.1002/fsn3.4696. eCollection 2025 Jan.
3
AILDE Computer-Aided Discovery of Novel Ibuprofen-Coumarin Antitumor Lead Compounds Targeting Cyclooxygenase-2.
AILDE计算机辅助发现靶向环氧合酶-2的新型布洛芬-香豆素抗肿瘤先导化合物
ACS Omega. 2024 Sep 19;9(39):41021-41031. doi: 10.1021/acsomega.4c06596. eCollection 2024 Oct 1.
4
Coumarin as an Elite Scaffold in Anti-Breast Cancer Drug Development: Design Strategies, Mechanistic Insights, and Structure-Activity Relationships.香豆素作为抗乳腺癌药物研发中的优良骨架:设计策略、作用机制及构效关系
Biomedicines. 2024 May 27;12(6):1192. doi: 10.3390/biomedicines12061192.
5
Latest developments in coumarin-based anticancer agents: mechanism of action and structure-activity relationship studies.基于香豆素的抗癌剂的最新进展:作用机制及构效关系研究
RSC Med Chem. 2023 Oct 20;15(1):10-54. doi: 10.1039/d3md00511a. eCollection 2024 Jan 25.
6
Developing multitarget coumarin based anti-breast cancer agents: synthesis and molecular modeling study.开发基于香豆素的多靶标抗乳腺癌药物:合成与分子模拟研究。
Sci Rep. 2023 Aug 17;13(1):13370. doi: 10.1038/s41598-023-40232-3.
7
An Understanding of Mechanism-Based Approaches for 1,3,4-Oxadiazole Scaffolds as Cytotoxic Agents and Enzyme Inhibitors.对基于机制的1,3,4-恶二唑支架作为细胞毒性剂和酶抑制剂的方法的理解。
Pharmaceuticals (Basel). 2023 Feb 7;16(2):254. doi: 10.3390/ph16020254.
8
α-Glucosidase and α-Amylase Inhibitory Potentials of Quinoline-1,3,4-oxadiazole Conjugates Bearing 1,2,3-Triazole with Antioxidant Activity, Kinetic Studies, and Computational Validation.具有抗氧化活性的含1,2,3-三唑的喹啉-1,3,4-恶二唑共轭物的α-葡萄糖苷酶和α-淀粉酶抑制潜力、动力学研究及计算验证
Pharmaceuticals (Basel). 2022 Aug 22;15(8):1035. doi: 10.3390/ph15081035.
9
Recent Advancements in the Development of Anti-Breast Cancer Synthetic Small Molecules.抗乳腺癌合成小分子药物研发的最新进展。
Molecules. 2021 Dec 15;26(24):7611. doi: 10.3390/molecules26247611.
10
Synthesis and Biological Screening of New 4-Hydroxycoumarin Derivatives and Their Palladium(II) Complexes.新型 4-羟基香豆素衍生物及其钯(II)配合物的合成与生物筛选。
Oxid Med Cell Longev. 2021 Apr 28;2021:8849568. doi: 10.1155/2021/8849568. eCollection 2021.